Exact Sciences
EXAS
EXAS was delisted on the 20th of March, 2026.
559 hedge funds and large institutions have $9.49B invested in Exact Sciences in 2025 Q2 according to their latest regulatory filings, with 98 funds opening new positions, 179 increasing their positions, 185 reducing their positions, and 93 closing their positions.
25% more funds holding in top 10
Funds holding in top 10: 4 → 5 (+1)
20% more capital invested
Capital invested by funds: $7.89B → $9.49B (+$1.59B)
5% more first-time investments, than exits
New positions opened: 98 | Existing positions closed: 93
0% more funds holding
Funds holding: 558 → 559 (+1)
3% less repeat investments, than reductions
Existing positions increased: 179 | Existing positions reduced: 185
3.51% less ownership
Funds ownership: 98.14% → 94.64% (-3.5%)
35% less call options, than puts
Call options by funds: $84.9M | Put options by funds: $130M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Massachusetts Financial Services
Boston,
Massachusetts
|
+$151M |
| 2 |
Goldman Sachs
New York
|
+$75.5M |
| 3 |
Holocene Advisors
New York
|
+$71.3M |
| 4 |
RAM
Readystate Asset Management
Chicago,
Illinois
|
+$45.4M |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
+$37.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$137M |
| 2 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
-$132M |
| 3 |
BlackRock
New York
|
-$70.5M |
| 4 |
State Street
Boston,
Massachusetts
|
-$62.7M |
| 5 |
UBS AM
Chicago,
Illinois
|
-$62M |
EXAS Hedge Fund Activity: Q2 2025 in Review
559 of the 7,598 institutional investors tracked by Wall St. Rank reported a position in Exact Sciences (EXAS) for Q2 2025, worth a combined $9.49B — up 20% from $7.89B a quarter earlier.
Buyers outnumbered sellers: 98 funds opened new EXAS positions and 93 closed out — a net gain of 5 holders — while 179 added to existing stakes and 185 trimmed.
The largest buyer was Massachusetts Financial Services, opening a new position worth an estimated $151M. The largest seller was T. Rowe Price Associates, cutting an estimated $137M.
- 559 institutional investors held Exact Sciences (EXAS) as of Q2 2025, up from 558 in Q1 2025.
- Funds reported $9.49B of Exact Sciences stock for Q2 2025, up 20% quarter-over-quarter.
- 98 funds opened new Exact Sciences positions in Q2 2025 and 93 closed out, a net change of +5 holders.
- The largest Exact Sciences buyer in Q2 2025 was Massachusetts Financial Services, an estimated $151M added.
- The largest Exact Sciences seller in Q2 2025 was T. Rowe Price Associates, an estimated $137M sold.
Based on aggregated 13F filings for Q2 2025.